Nimbus Therapeutics

Nimbus Therapeutics

Biotechnology Research 22 Boston Wharf Rd 106 employees THIS
Employees
106
Contacts
2
Emails
2

Nimbus Therapeutics Overview

Headquarters
22 Boston Wharf Rd
Phone Number
Available in AeroLeads
Website
nimbustx.com
Industry
Biotechnology Research
Employees
106
Founded
2009
Stock Symbol
THIS
Funding
210.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Nimbus Therapeutics

Nimbus Therapeutics is a clinical-stage, structure-based drug discovery company developing novel small molecule medicines designed to act against well-validated but difficult-to-drug targets implicated in multiple human diseases. The company advances promising research based on a unique strategy that combines leading-edge computational technologies with a tailored array of machine learning-based predictive modeling approaches. Nimbus' pipeline includes a clinical-stage HPK1 inhibitor for the treatment of cancer (NCT05128487), as well as a diverse portfolio of preclinical programs focused on cancer, including a WRN program for MSI-H cancers, autoimmune conditions, and metabolic diseases.

Nimbus Therapeutics Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage

Nimbus Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Joshua Mcelwee
Email
Erin Cowhig Former Chief People Officer at Nimbus
Email
Ralph Swanson Greater Boston Contracts Professional
View
Jeb Keiper Former Chief Executive Officer
View

Employees by Management Level

Individual contributor 11 profiles
Executive 3 profiles
Manager 2 profiles
Senior / Lead 2 profiles
Associate / junior 2 profiles
Director 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 6 6 2
Operations 1 1 1

Nimbus Therapeutics Tech Stack

Data / AI 3 profiles
Engineering 1 profile

Compare Similar Companies to Nimbus Therapeutics